
1. plos one. 2014 aug 26;9(8):e105922. doi: 10.1371/journal.pone.0105922.
ecollection 2014.

expression levels pvcrt-o pvmdr-1 associated chloroquine
resistance severe plasmodium vivax malaria patients brazilian
amazon.

melo gc(1), monteiro wm(2), siqueira am(1), silva sr(3), magalhães bm(1), alencar
ac(1), kuehn a(4), del portillo ha(5), fernandez-becerra c(6), lacerda mv(2).

author information: 
(1)universidade estado amazonas, manaus, amazonas, brazil.
(2)universidade estado amazonas, manaus, amazonas, brazil; fundação de
medicina tropical dr. heitor vieira dourado, manaus, amazonas, brazil.
(3)universidade paulista unip, manaus, amazonas, brazil.
(4)fundação de medicina tropical dr. heitor vieira dourado, manaus, amazonas,
brazil; barcelona centre international health research (cresib, hospital
clínic-universitat de barcelona), barcelona, spain.
(5)barcelona centre international health research (cresib, hospital
clínic-universitat de barcelona), barcelona, spain; institució catalana de
recerca estudis avançats (icrea), barcelona, spain.
(6)barcelona centre international health research (cresib, hospital
clínic-universitat de barcelona), barcelona, spain.

molecular markers associated increase chloroquine resistance and
disease severity plasmodium vivax needed. objective study 
to evaluate expression levels pvcrt-o pvmdr-1 genes group of
patients presenting cqrpv patients developed severe complications
triggered exclusively p. vivax infection. two different sets patients 
included comprehensive study performed brazilian amazon: 1)
patients clinically characterized chloroquine-resistant p. vivax compared
with patients susceptible parasites vivo studies 2) patients
with severe vivax malaria compared patients without severity. quantitative
real-time pcr performed compare transcript levels two main
transporters genes, p. vivax chloroquine resistance transporter (pvcrt-o) the
p. vivax multidrug resistance transporter (pvmdr-1). twelve chloroquine resistant
cases 15 isolates susceptible cases included first set
of patients. second set, seven patients p. vivax-attributed severe
and 10 mild manifestations included. parasites patients with
chloroquine resistance presented 6.1 (95% ci: 3.8-14.3) 2.4 (95% ci:
0.53-9.1) fold increase pvcrt-o pvmdr-1 expression levels, respectively,
compared susceptible group. parasites severe vivax group a
2.9 (95% ci: 1.1-8.3) 4.9 (95% ci: 2.3-18.8) fold increase pvcrt-o and
pvmdr-1 expression levels compared control group mild disease.
these findings suggest chloroquine resistance clinical severity p.
vivax infections strongly associated increased expression levels 
pvcrt-o pvmdr-1 genes likely involved chloroquine resistance.

doi: 10.1371/journal.pone.0105922 
pmcid: pmc4144906
pmid: 25157811  [indexed medline]

